Detalles de la búsqueda
1.
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
JAMA Dermatol
; 160(3): 290-296, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38265821
2.
Pustular Lichenoid Eruptions Induced by Immune Checkpoint Inhibitors: Two Case Reports and a Review of the Literature.
J Immunother
; 46(2): 59-63, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36622668
3.
Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus.
J Invest Dermatol
; 141(9): 2132-2140.e1, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33766510
4.
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
JAMA Dermatol
; 156(5): 545-552, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32186656
5.
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma.
J Oncol
; 2018: 1908065, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30631354
6.
Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib.
JAAD Case Rep
; 3(6): 532-533, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29296640
Resultados
1 -
6
de 6
1
Próxima >
>>